The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction.
Open Access
- 1 February 1994
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 179 (2) , 715-720
- https://doi.org/10.1084/jem.179.2.715
Abstract
Interaction of CD28/CTLA-4 on T cells with B7 on antigen-presenting cells constitutes an important costimulatory signal for T cells and is responsible for cyclosporin A-resistant interleukin 2 (IL-2) gene expression and potentially also for prevention of anergy induction after T cell receptor triggering. In this paper, we demonstrate that addition of a monoclonal antibody to B7, which blocks B7-CD28/CTLA-4 interaction, and of cyclosporin A together, but not separately, to a primary mixed lymphocyte reaction of freshly isolated human T cells towards a human B cell line, induces nonresponsiveness of alloantigen-specific cytotoxic T lymphocyte precursors, whereas reactivity to a third party stimulator is intact. Nonresponsiveness could be reversed by culture in IL-2, indicating that anergy, and not clonal deletion, is responsible for this phenomenon. Our finding opens important perspectives for the development of new therapeutic strategies in transplantation.Keywords
This publication has 29 references indexed in Scilit:
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- In situ expression of B7/BB1 on antigenpresenting cells and activated B cells: an immunohistochemical studyInternational Immunology, 1993
- Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.The Journal of Experimental Medicine, 1993
- Functional characterization of a novel anti‐B7 monoclonal antibodyEuropean Journal of Immunology, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.The Journal of Experimental Medicine, 1992
- Split Anergy in a CD8 + T Cell: Receptor-dependent Cytolysis in the Absence of Interleukin-2 ProductionScience, 1991
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990
- The influence of cyclosporin A on the alternative pathways of human T cell activation in vitroEuropean Journal of Immunology, 1989
- Transmembrane signalling via the T11‐dependent pathway of human T cell activation. Evidence for the involvement of 1,2‐diacylglycerol and inositol phosphatesEuropean Journal of Immunology, 1987